Prime Therapeutics signs outcomes-based contract with Novo Nordisk for type 2 diabetes drug Victoza (liraglutide). As the rate of diabetes continues to escalate in the United States, health care payers are looking for solutions to help manage the cost of treating this serious disease while helping to ensure quality health care for their members. This has…